Recruiting Myelodysplastic Syndromes Studies in Palo Alto
About Myelodysplastic Syndromes Clinical Trials in Palo Alto
Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature properly. MDS can progress to acute myeloid leukemia. Treatments include growth factors, chemotherapy, and stem cell transplant.
There are currently 1 myelodysplastic syndromes clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 86 participants. Research is being sponsored by Rigel Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myelodysplastic Syndromes Clinical Trials in Palo Alto — FAQ
Are there myelodysplastic syndromes clinical trials in Palo Alto?
Yes, there are 1 myelodysplastic syndromes clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What myelodysplastic syndromes treatments are being tested?
The 1 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for myelodysplastic syndromes.
Data updated October 16, 2026 from ClinicalTrials.gov